Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Raghunath

FOUND: Is gilead sciences stock a buy near 52 week lows for its 4 yield - You Need To See This

After trouncing the broader markets between 2004 and 2015, Gilead Sciences (GILD) has underperformed significantly in the last eight years. By the numbers, Gilead Sciences stock rose 1,550% between February 2004 and August 2015, when it traded near all-time highs. Today, the healthcare giant is down about 41% from record levels, valuing the company at a market cap of $89 billion. 

www.barchart.com
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.